Healthcare providers world-wide increasingly recognise the power of diagnostics to reduce the cost and enhance the efficiency of health management. Biotools's Diagnostics Division intends to make a contribution to both. Our portfolio of innovative diagnostic tests and systems play a pivotal role in the groundbreaking area of integrated healthcare solutions.
We offer a wide range of products and services in different fields of medical testing. We have a technological capacity to provide innovative, cost-effective and reliable solutions in biomedical research and laboratory diagnostics. We are dedicated to working with our customers, researchers and clinicians to help them to meet their specific needs.
Biotools has exploited a new technology, the “LIONPROBES® technique” in order to develop sensitive and reliable detection Real Time Amplification Assays. This technology is based on the use of a DNA polymerase with 3´-5´exonuclease proofreading activity (Pfu) and a double labelled oligonucleotide (5´TAMRA—FAM3´) which presents a mismatch at 3´end of the hybridization area. During the amplification, the Pfu recognises the 3´mismatch and excises the mismatched base pairs labelled with the fluorophore (FAM). Once this mismatch is corrected amplification priming is enabled by the oligonucleotide. During amplification cycles the fluorescence emerges as result of the release of the fluorophore.
For additional information about Biotools Diagnostic products and integral solutions, please contact us directly to firstname.lastname@example.org